FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,643 Cr | ₹3,317 Cr | ₹3,180 Cr | ₹3,038 Cr | ₹2,655 Cr |
What is the latest Total Liabilities ratio of FDC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,643 Cr |
| Mar2024 | ₹3,317 Cr |
| Mar2023 | ₹3,180 Cr |
| Mar2022 | ₹3,038 Cr |
| Mar2021 | ₹2,655 Cr |
How is Total Liabilities of FDC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,643 Cr | 9.85 | |
| Mar2024 | ₹3,317 Cr | 4.31 | |
| Mar2023 | ₹3,180 Cr | 4.66 | |
| Mar2022 | ₹3,038 Cr | 14.41 | |
| Mar2021 | ₹2,655 Cr | - | |
Compare Total Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,067.1 Cr | 6.1% | 10.5% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 6.1% |
10.5% |
-8.7% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses